EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Purification and pharmacokinetic study of gadoxetate isomers for enhanced rabbit liver MR imaging

Yiling Chang iD, Qilin Li, Man Yi, JiGen Li, Xiaodong Yuan iD

PLOS One · 05.03.2026 · 21 (3) · e0343927

DOI: 10.1371/journal.pone.0343927 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 05.03.2026. Verfasst von Yiling Chang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Special Service Recuperation Center of PLA Rocket Force, Guangzhou, China. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Liver, Gadolinium DTPA, Contrast Media. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to purify and prepare two isomers of Gadoxetate (Gd-A and Gd-B) from Pumexian and evaluate their stability, magnetic resonance (MR) imaging characteristics, and pharmacokinetics in rabbits. Reversed-phase liquid chromatography was employed to separate Gd-A and Gd-B, achieving purities exceeding 99% for both isomers. These purified isomers were then processed into vacuum-encapsulated solid powders via nitrogen blowing and freeze-drying. Stability assessments were conducted by storing the powders at various temperatures (25°C, −20°C, 50°C, and 80°C) for two months. The results indicated high stability at room temperature (25°C) and low temperature (−20°C), with both Gd-A and Gd-B maintaining 99% purity. At higher temperatures, purity slightly decreased: Gd-A was 98% at 50°C and 95% at 80°C, while Gd-B was 97% at 50°C and 94% at 80°C. For the in vivo evaluation, twelve rabbits were randomly assigned to two groups and received intravenous bolus injections of either pure Gd-A or Gd-B, followed by enhanced MR scanning and serial blood sampling. Pharmacokinetic and imaging analyses revealed statistically significant differences (p < 0.05) between the two isomers. Specifically, Gd-A exhibited a shorter time to peak enhancement in liver parenchyma (t peak A < t peak B), higher peak signal intensity in the liver parenchyma (SI peak A > SI peak B), greater plasma clearance (PCL-A > PCL-B), and a shorter half-life (t 1/2 A < t 1/2 B) compared to Gd-B. In conclusion, the vacuum-encapsulated solid powders of Gd-A and Gd-B demonstrate good long-term stability at room or low temperatures while maintaining high purity. Furthermore, the distinct pharmacokinetic profile and imaging characteristics of pure Gd-A suggest its potential value for clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingLiverGadolinium DTPAContrast MediaAnimalsRabbitsIsomerismMale

Substanzen

Gadolinium DTPAContrast Mediagadolinium ethoxybenzyl DTPA

Autor:innen und Institutionen

  • Guangzhou Special Service Recuperation Center of PLA Rocket Force, Guangzhou, China.
  • 309th Hospital of PLA: 8th Medical Center of Chinese PLA General Hospital, Beijing, China.

ORCID-Profile: Yiling Chang, Xiaodong Yuan

Zitieren

APA

Chang, Y., Li, Q., Yi, M., Li, J., & Yuan, X. (2026). Purification and pharmacokinetic study of gadoxetate isomers for enhanced rabbit liver MR imaging. PLOS One, 21(3), e0343927. https://doi.org/10.1371/journal.pone.0343927

Vancouver

Chang Y, Li Q, Yi M, Li J, Yuan X. Purification and pharmacokinetic study of gadoxetate isomers for enhanced rabbit liver MR imaging. PLOS One. 2026;21(3):e0343927. doi:10.1371/journal.pone.0343927

BibTeX
@article{Chang2026,
  author = {Chang, Yiling and Li, Qilin and Yi, Man and Li, JiGen and Yuan, Xiaodong},
  title = {Purification and pharmacokinetic study of gadoxetate isomers for enhanced rabbit liver MR imaging},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {e0343927},
  doi = {10.1371/journal.pone.0343927}
}
Kostenlos starten →